NCT06765876
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06765876
Title CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: a Dose Escalation Phase I Trial (UHKT-CAR123-01)
Acronym UHKT-CAR123-01
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Institute of Hematology and Blood Transfusion, Czech Republic
Indications
Therapies
Age Groups: adult | senior
Covered Countries CZE


No variant requirements are available.